15 January 2015
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has today received notification from James Barder, the Chief Executive of the Company, that he and his wife have gifted in aggregate 50,000 ordinary shares in the Company to a shareholding account jointly held by their children.
Following the transfer, Mr. Barder's revised aggregate beneficial and non-beneficial holding is 958,830 ordinary shares, representing 0.97 per cent. of the Company's issued share capital.
For further information please contact:
Aubrey Powell / Liz Yong
Tel: +44 (0) 20 7496 3000
For media enquiries please contact:
Mark Court / Sophie Wills /
Stephanie Watson / Tilly Abraham
Tel: +44 (0) 20 7466 5000
Notes to editors:
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.